MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Co-Diagnostics ROCE Ratio 2011-2026 | CODX
Annual ROCE Ratio Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -236.6 | -71.26 | -47.91 | -22.63 | 31.24 | 62.48 | -312.29 | 765.87 | -113.14 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 765.87 | -312.29 | 6.2 |
Quarterly ROCE Ratio Co-Diagnostics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106.61 | -68.49 | -61.59 | -55.83 | -38.65 | -47.28 | -43.05 | -41.63 | -28.54 | -33.15 | -27.21 | -9.86 | -1.09 | 12.38 | 30.38 | 46.52 | 40.31 | 58.35 | 66.93 | 51.92 | 38.46 | -48.05 | -136.6 | -225.11 | -223.49 | -15.21 | 240.73 | 471.15 | 537.62 | 497.63 | 273.4 | 91.13 | -68.78 | -53.39 | 1.9 | -12.84 | - | 15.39 | 15.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 537.62 | -225.11 | 30.08 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B |  USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 18.53 | 1.59 % | $ 570 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 128.89 | -3.25 % | $ 16.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 137.76 | 0.7 % | $ 10.8 B |  Irlanda |
 |
Agilent Technologies
A
|
25.0 | $ 137.36 | 1.46 % | $ 41.8 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.7 | -5.56 % | $ 7.52 M | USA |
 |
Celcuity
CELC
|
-171.24 | $ 132.9 | 1.52 % | $ 6.21 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.21 | -4.07 % | $ 615 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 22.88 | 0.79 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 164.99 | 4.03 % | $ 26.2 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 99.99 | 0.37 % | $ 6.75 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 178.15 | 1.13 % | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 10.59 | 3.88 % | $ 1.36 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.8 | 0.71 % | $ 443 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 221.23 | 3.41 % | $ 21.8 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 184.01 | 1.47 % | $ 9.12 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 452.2 | 0.91 % | $ 13 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.01 | -5.09 % | $ 371 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 11.43 | 4.1 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.53 | 0.28 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.74 | 0.3 % | $ 281 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.39 | -1.74 % | $ 5.49 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 68.81 | -0.32 % | $ 4.12 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 262.23 | 0.08 % | $ 21.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 496.35 | 1.87 % | $ 187 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.71 | 1.24 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.18 | -1.34 % | $ 1.99 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 195.62 | -0.3 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |